Related Experiment Video
Updated: Jun 26, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
The evolving landscape of acute kidney injury: research directions and changes in clinical practice
Sangyub Han1, Sejoong Kim2,3,4, Keonhwa Kim5
1Seoul National University College of Medicine, Republic of Korea.
Abstract:
Acute kidney injury (AKI) is a common and serious disease, needing a comprehensive and management-based approach. While traditional practice focused on management after occurrence, recent practice is expanding its focus to prevention and novel therapeutic strategies, using new discoveries in AKI research. New biomarkers have been approved along with therapeutic agents, which target different pathophysiological pathways of AKI. In this review, we first summarize the current understanding of AKI definition and epidemiology, including global disparities and recent changes related to pandemics. Next, we highlight recent research directions regarding biomarkers, therapeutic agents, continuous renal replacement therapy, digital healthcare and artificial intelligence, and global collaborations. The aim of this review is to provide a comprehensive view of the direction in which AKI research is heading and link these areas to changes that are happening in clinical practice, with a goal to push innovative research accomplishments.
Insights
Acute kidney injury (AKI) research is advancing with new biomarkers and therapies targeting its pathways. This review highlights emerging directions in AKI research and clinical practice for improved patient outcomes.
Area of Science:
- Nephrology
- Internal Medicine
- Biomarker Research
Background:
- Acute kidney injury (AKI) is a prevalent and severe condition requiring comprehensive management.
- Traditional AKI care focused on post-occurrence treatment, but current practice emphasizes prevention and novel therapeutic strategies.
- Recent AKI research has led to the approval of new biomarkers and targeted therapeutic agents.
Purpose of the Study:
- To provide a comprehensive overview of current and emerging trends in acute kidney injury research.
- To connect advancements in AKI research with evolving clinical practices.
- To stimulate innovative research and clinical advancements in AKI management.
Main Methods:
- Review of current literature on acute kidney injury definition, epidemiology, and global disparities.
- Analysis of recent research in AKI biomarkers, therapeutics, and continuous renal replacement therapy.
- Exploration of the role of digital healthcare, artificial intelligence, and global collaborations in AKI research.
Main Results:
- Summarizes current understanding of AKI definition and epidemiology, including pandemic-related changes.
- Highlights progress in AKI biomarkers, therapeutic agents targeting pathophysiological pathways, and continuous renal replacement therapy.
- Discusses the integration of digital health, AI, and global collaborations in advancing AKI research and care.
Conclusions:
- AKI research is rapidly evolving, shifting towards prevention and targeted therapies.
- Integration of new biomarkers, advanced therapies, digital health, and AI is crucial for future AKI management.
- Bridging research discoveries with clinical practice is essential to drive innovation and improve outcomes in AKI.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury VI: Nursing Management